These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 9449570)

  • 21. Development of HPLC conditions for valid determination of hydrolysis products of cisplatin.
    El-Khateeb M; Appleton TG; Charles BG; Gahan LR
    J Pharm Sci; 1999 Mar; 88(3):319-26. PubMed ID: 10052990
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Poly(styrene-alt-maleic anhydride)-based diblock copolymer micelles exhibit versatile hydrophobic drug loading, drug-dependent release, and internalization by multidrug resistant ovarian cancer cells.
    Baranello MP; Bauer L; Benoit DS
    Biomacromolecules; 2014 Jul; 15(7):2629-41. PubMed ID: 24955779
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Doxorubicin prodrugs with reduced cytotoxicity suited for tumour-specific activation.
    Desbène S; Van HD; Michel S; Koch M; Tillequin F; Fournier G; Farjaudon N; Monneret C
    Anticancer Drug Des; 1998 Dec; 13(8):955-68. PubMed ID: 10335269
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microwave-Assisted Hydrothermal Rapid Synthesis of Amorphous Calcium Phosphate Mesoporous Microspheres Using Adenosine 5'-Diphosphate and Application in pH-Responsive Drug Delivery.
    Qi C; Zhu YJ; Sun TW; Wu J; Chen F
    Chem Asian J; 2015 Nov; 10(11):2503-11. PubMed ID: 26248600
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparison of the stability of doxorubicin and daunorubicin in solid state.
    Cielecka-Piontek J; Jelińska A; Zajac M; Sobczak M; Bartold A; Oszczapowicz I
    J Pharm Biomed Anal; 2009 Nov; 50(4):576-9. PubMed ID: 19195811
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PEG-b-PCL copolymer micelles with the ability of pH-controlled negative-to-positive charge reversal for intracellular delivery of doxorubicin.
    Deng H; Liu J; Zhao X; Zhang Y; Liu J; Xu S; Deng L; Dong A; Zhang J
    Biomacromolecules; 2014 Nov; 15(11):4281-92. PubMed ID: 25325531
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PEGylated and poloxamer-modified chitosan nanoparticles incorporating a lysine-based surfactant for pH-triggered doxorubicin release.
    Scheeren LE; Nogueira DR; Macedo LB; Vinardell MP; Mitjans M; Infante MR; Rolim CM
    Colloids Surf B Biointerfaces; 2016 Feb; 138():117-27. PubMed ID: 26674840
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Doxorubicin-loaded drug-eluting beads (DC Bead®) for use in transarterial chemoembolization: a stability assessment.
    Hecq JD; Lewis AL; Vanbeckbergen D; Athanosopoulos A; Galanti L; Jamart J; Czuczman P; Chung T
    J Oncol Pharm Pract; 2013 Mar; 19(1):65-74. PubMed ID: 22801955
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Investigation of the retention/pH profile of zwitterionic fluoroquinolones in reversed-phase and ion-interaction high performance liquid chromatography.
    Pistos C; Tsantili-Kakoulidou A; Koupparis M
    J Pharm Biomed Anal; 2005 Sep; 39(3-4):438-43. PubMed ID: 15894451
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HPLC quantification of doxorubicin in plasma and tissues of rats treated with doxorubicin loaded poly(alkylcyanoacrylate) nanoparticles.
    Alhareth K; Vauthier C; Gueutin C; Ponchel G; Moussa F
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Mar; 887-888():128-32. PubMed ID: 22341684
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Doxorubicin-loaded biodegradable self-assembly zein nanoparticle and its anti-cancer effect: Preparation, in vitro evaluation, and cellular uptake.
    Dong F; Dong X; Zhou L; Xiao H; Ho PY; Wong MS; Wang Y
    Colloids Surf B Biointerfaces; 2016 Apr; 140():324-331. PubMed ID: 26764113
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fabrication of doxorubicin nanoparticles by controlled antisolvent precipitation for enhanced intracellular delivery.
    Tam YT; To KK; Chow AH
    Colloids Surf B Biointerfaces; 2016 Mar; 139():249-58. PubMed ID: 26724466
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Separation of penicillin and its major degradation products by ion-pair reversed-phase high-pressure liquid chromatography.
    Ghebre-Sellassie I; Hem SL; Knevel AM
    J Pharm Sci; 1982 Mar; 71(3):351-3. PubMed ID: 6279818
    [TBL] [Abstract][Full Text] [Related]  

  • 34. pH-sensitive poly(glutamic acid) grafted mesoporous silica nanoparticles for drug delivery.
    Zheng J; Tian X; Sun Y; Lu D; Yang W
    Int J Pharm; 2013 Jun; 450(1-2):296-303. PubMed ID: 23598077
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of the eluent pH and acidic modifiers in high-performance liquid chromatography retention of basic analytes.
    LoBrutto R; Jones A; Kazakevich YV; McNair HM
    J Chromatogr A; 2001 Apr; 913(1-2):173-87. PubMed ID: 11355811
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fabrication of double-walled microspheres for the sustained release of doxorubicin.
    Tan EC; Lin R; Wang CH
    J Colloid Interface Sci; 2005 Nov; 291(1):135-43. PubMed ID: 15964579
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polyhydroxybutyrate-coated magnetic nanoparticles for doxorubicin delivery: cytotoxic effect against doxorubicin-resistant breast cancer cell line.
    Yalcin S; Unsoy G; Mutlu P; Khodadust R; Gunduz U
    Am J Ther; 2014; 21(6):453-61. PubMed ID: 25137407
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assay of doxorubicin and 4'-epidoxorubicin by reversed-phase ion-pair chromatography.
    Thomas AH; Quinlan GJ; Gutteridge JM
    J Chromatogr; 1984 Sep; 299(2):489-94. PubMed ID: 6594342
    [No Abstract]   [Full Text] [Related]  

  • 39. Synthesis and evaluation of pH-sensitive, self-assembled chitosan-based nanoparticles as efficient doxorubicin carriers.
    Raja MA; Arif M; Feng C; Zeenat S; Liu CG
    J Biomater Appl; 2017 Mar; 31(8):1182-1195. PubMed ID: 28081668
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antisense oligonucleotide delivery with polyhexylcyanoacrylate nanoparticles as carriers.
    Zimmer A
    Methods; 1999 Jul; 18(3):286-95, 322. PubMed ID: 10454987
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.